Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders
Assessing the Efficacy and Acceptability of the Satir Model on Self-esteem and Mental Health Among Individuals With Substance Use Disorders in China: A Pilot Study Protocol
1 other identifier
interventional
45
1 country
1
Brief Summary
Self-esteem and family functioning are associated with mental health and success of drug treatment among individuals with substance use disorders (SUD). The Satir model aims to empower individuals to explore their internal resources, address emotional issues, shift coping strategies, enhancing self-esteem, and develop healthier ways of relating to themselves and others. It offers a range of techniques to enhance self-esteem, challenging negative belief systems, and promote personal growth. The aim of the study is to investigate the acceptability and preliminary efficacy of the Satir model on self-esteem, mental health, and family function among individuals with SUD in China. The study will adopt a mixed-method approach. The quantitative phase will employ a randomized control trial (RCT) utilizing a pre-post study design. The qualitative phase will involve conducting semi-structured individual interviews.The data will be analyzed by using SPSS software package (IBM SPSS statistics version 26.0). The individual-interview will be analyzed by using the six-phase thematic analysis. The study has the potential to advance knowledge in the field of drug rehabilitation interventions, inform evidence-based practice, and improve the wellbeing and outcomes of individual with SUD. It can contribute to the ongoing efforts to address the complex challenges associated with substance use and support individual on their trajectory to recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2023
CompletedFirst Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedOctober 23, 2023
October 1, 2023
8 days
September 11, 2023
October 18, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Self-esteem
The changes of participants' self-esteem will be assessed by using the Chinese version of Rosenberg self-esteem scale. Total scores range from 10 to 40, with higher scores representing lower self-esteem.
Through study completion, an average of two months
Secondary Outcomes (9)
Adult attachment
Through study completion, an average of two months
Coping style
Through study completion, an average of two months
Self-efficacy
Through study completion, an average of two months
Meaning in life
Through study completion, an average of two months
Resilience
Through study completion, an average of two months
- +4 more secondary outcomes
Study Arms (2)
Satir group
EXPERIMENTALParticipants in the intervention group will receive a 10-session Satir model intervention.
Control group
NO INTERVENTIONParticipants in the control group will receive care as usual.
Interventions
Participants in the intervention group will receive a 10-session, 3-hour/session intervention that spans over a period of five days (2 sessions/day). The intervention program will be conducted on specific weekends, with a gap of 1 to 2 weeks. The total duration of the intervention will be 30 hours.
Eligibility Criteria
You may qualify if:
- aged 18 or above;
- are able to speak, read, and write Chinese;
- are willing to participate in the study and share their experience of the intervention with the research group;
- have informed consent to participate in the study.
You may not qualify if:
- have been diagnosed with severe mental illnesses, such as schizophrenia, mania, antisocial personality disorder;
- have a diagnosed memory and cognitive impairment;
- are undergoing psychotherapeutic or psychopharmacologic treatment;
- are participating in similar studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fangqiang compulsory isolation detoxification center
Yancheng, Jiangsu, 224000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Haixia Ma, PhD
Hong Kong Metropolitan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Open trial
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 11, 2023
First Posted
September 21, 2023
Study Start
September 1, 2023
Primary Completion
September 9, 2023
Study Completion
September 30, 2023
Last Updated
October 23, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ICF, CSR
- Time Frame
- After the project is completed and the results of the project have been published.
- Access Criteria
- Request could be sent to Principal Investigator (phxma@hkmu.edu.hk)
The relevant anonymized participant-level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.